The latter, which suppresses tumor growth by CD44 downregulation (82), is abundantly expressed in CD44v6 knockdown (CD44v6kd) cells, which argues for CD44v6 to be engaged in miR-34a silencing. The gene discussed is CD44; the disease is neoplasm.